Scientific evidence supports the notion that migraine pathophysiology involves inherited alteration of brain excitability, intracranial arterial dilatation, recurrent activation, and sensitization of the trigeminovascular pathway, and consequential structural and functional changes in genetically susceptible individuals. Evidence of altered brain excitability emerged from clinical and preclinical investigation of sensory auras, ictal and interictal hypersensitivity to visual, auditory, and olfactory stimulation, and reduced activation of descending inhibitory pain pathways. Data supporting the activation and sensitization of the trigeminovascular system include the progressive development of cephalic and whole-body cutaneous allodynia during a migraine attack. In addition, structural and functional alterations include the presence of subcortical white mater lesions, thickening of cortical areas involved in processing sensory information, and cortical neuroplastic changes induced by cortical spreading depression. Here, we review recent anatomical data on the trigeminovascular pathway and its activation by cortical spreading depression, a novel understanding of the neural substrate of migraine-type photophobia, and modulation of the trigeminovascular pathway by the brainstem, hypothalamus and cortex. Ó
Introduction
Migraine is a disabling neurovascular disorder characterized by mostly unilateral throbbing head pain and a host of neurological symptoms including hypersensitivity to light, sound, and smell; nausea; and a variety of autonomic, cognitive, emotional, and motor disturbances [73, 94] . Although the initiation of a migraine attack is frequently associated with a wide variety of internal and external triggers such as stress, hormonal fluctuations, sleep disturbances, meal skipping, or sensory overload [54, 70] , the neural and vascular mechanisms underlying the development of this primary condition remain to be elucidated. Because of the complexity of this disorder, which is not limited to its multifactorial origin but also includes remarkable premonitory symptomatology, it is thought that migraine headache is a manifestation of a brain state of altered excitability capable of activating the trigeminovascular system in genetically susceptible individuals [24, 101, 119 ].
An estimated 16% of the worldwide population suffer from migraine headache, and about one-third of those migraines are preceded by neurological symptoms associated with a transient cortical malfunction, collectively known as aura [66, 124] . Such cortical disturbances arise from the phenomenon of cortical spreading depression (CSD), which occurs spontaneously in the human cortex before the onset of the headache [18, 43] . The susceptibility for its occurrence likely depends on genetic factors that render the cerebral cortex hyperexcitable through abnormal excitatory/inhibitory balance [128] . Although there is a large body of evidence that supports the role of CSD as a key event for the activation of the trigeminovascular system [16, 86, 136, 137] , scientific evidence of asymptomatic CSD-like events in migraine without aura remain to be provided. This review will focus on relevant preclinical and clinical data that improve our understanding of the pathophysiology of migraine and its associated symptoms.
Anatomical substrate of the trigeminovascular pain pathways

Peripheral innervation of the trigeminovascular system
The headache phase of a migraine attack is thought to originate in activation of nociceptors innervating pial, arachnoid, and dural
